Concise review: Anemia caused by viruses

Stem Cells

Volumn 29, Issue 11, 2011, Pages 1656-1660

  Morinet, Frédéric ^a,b   Leruez Ville, Marianne ^c   Pillet, Sylvie ^d,e   Fichelson, Serge ^b,f  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^e UNIVERSITÉ DE LYON   (France)

^f INSTITUT COCHIN   (France)

Author keywords

Aplastic anemia; Erythroid progenitors; Parvovirus B19; Pure red cell aplasia; Viruses

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CHLOROQUINE;

ANEMIA; ANTIVIRAL THERAPY; APLASTIC ANEMIA; CYTOMEGALOVIRUS INFECTION; CYTOTOXICITY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS INFECTION; ERYTHROID PRECURSOR CELL; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HEMATOPOIETIC STEM CELL; HEPATITIS A; HEPATITIS C; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PARVOVIRUS B19; MALARIA; NONHUMAN; PARVOVIRUS INFECTION; PURE RED CELL ANEMIA; SHORT SURVEY; SICKLE CELL ANEMIA; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS REACTIVATION; VIRUS REPLICATION;

ANEMIA; ANEMIA, APLASTIC; HUMANS; PARVOVIRIDAE INFECTIONS; VIRUSES;

ANIMALIA; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS; NON-A, NON-B HEPATITIS VIRUS; PARVOVIRUS;

EID: 80054899396     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.725     Document Type: Short Survey

References (54)

1. Brown KE, Young NS. Parvoviruses and bone marrow failure. Stem Cells 1996;14:151-163. (Pubitemid 26109197)
2. Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004;350:586-597.
3. Servant-Delmas A, Lefrere JJ, Morinet F et al. Advances in human B19 erythrovirus biology. J Virol 2010;84:9658-9665.
4. Tsiftsoglou AS, Vizirianakis IS, Strouboulis J. Erythropoiesis: model systems, molecular regulators, and developmental programs. IUBMB Life 2009;61:800-830.
5. Wojchowski DM, Sathyanarayana P, Dev A. Erythropoietin receptor response circuits. Curr Opin Hematol 2010;17:169-176.
6. Chen AY, Guan W, Lou S et al. Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells. J Virol 2010;84:12385-12396.
7. Luo Y, Lou S, Deng X et al. Parvovirus B19 infection of human primary erythroid progenitor cells triggers ATR-Chk1 signaling, which promotes B19 virus replication. J Virol 2011;85:8046-8055.
8. Weitzman MD, Lilley C, Chaurushiya MS. Genomes in conflict: maintaining genome integrity during virus infection. Annu Rev Microbiol 2010;64:61-81.
9. Ciccia A, Elledge SJ. The DNA damage response: Making it safe to play with knives. Mol Cell 2010;40:179-204.
10. Wan Z, Zhi N, Wong S et al. Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors. J Clin Invest 2010;120:3530-3544.
11. Sol N, Le Junter J, Vassias I et al. Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol 1999;73:8762-8770. (Pubitemid 29441741)
12. Chen AY, Zhang EY, Guan W et al. The small 11 kDa nonstructural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells. Blood 2010;115:1070-1080.
13. Zadori Z, Szelei J, Lacoste MC et al. A viral phospholipase A2 is required for parvovirus infectivity. Dev Cell 2001;1:291-302. (Pubitemid 33653063)
14. Pillet S, Le Guyader N, Hofer T et al. Hypoxia enhances human B19 erythrovirus gene expression in primary erythroid cells. Virology 2004;327:1-7. (Pubitemid 39140940)
15. Chen AY, Kleiboeker S, Qiu J. Productive parvovirus B19 infection of primary human erythroid progenitor cells at hypoxia is regulated by Stat5A and MEK signalling but not HIFa. PLoS Pathog 2011;7:e1002088.
16. Kaelin WG, Ratcliffe PJ. Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway. Mol Cell 2008;30:393-402. (Pubitemid 351681994)
17. Majmundar AJ, Wong WJ, Simon MC. Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 2010;40:294-309.
18. Cipolleschi MG, Dello Sbarba P, Olivotto M. The role of hypoxia in the maintenance of hematopoietic stem cells. Blood 1993;82:2031-2037. (Pubitemid 23293984)
19. Harrison JS, Rameshwar P, Chang V et al. Oxygen saturation in the bone marrow of healthy volunteers. Blood 2002;99:394.
20. Guan W, Wong S, Zhi N et al. The genome of human parvovirus b19 can replicate in nonpermissive cells with the help of adenovirus genes and produces infectious virus. J Virol 2009;83:9541-9553.
21. Bonsch C, Kempf C, Mueller I et al. Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replication. Plos Negl Trop Dis 2010;4:e669.
22. Wildig J, Michon P, Siba P et al. Parvovirus B19 infection contributes to severe anemia in young children in Papua New Guinea. J Infect Dis 2006;194:146-153. (Pubitemid 44087184)
23. Penchansky L, Jordan JA. Transient erythroblastopenia of childhood associated with human herpesvirus type 6, variant B. Am J Clin Pathol 1997;108:127-132. (Pubitemid 27328284)
24. Imbert-Marcille BM, Tang XW, Lepelletier D et al. Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: A single-center prospective longitudinal study of 92 patients. Clin Infect Dis 2000;31:881-886. (Pubitemid 32299342)
25. Lagadinou ED, Marangos M, Liga M et al. Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet. Transpl Infect Dis 2010;12:437-440.
26. Knox KK, Carrigan DR. In vitro suppression of bone marrow progenitor cell differentiation by human herpesvirus 6 infection. J Infect Dis 1992;165:925-929.
27. Isomura H, Yamada M, Yoshida M et al. Suppressive effects of human herpesvirus 6 on in vitro colony formation of hematopoietic progenitor cells. J Med Virol 1997;52:406-412. (Pubitemid 27356188)
28. Kumar V, Gupta S, Singh S et al. Pure red cell aplasia associated with cytomegalovirus infection. J Pediatr Hematol Oncol 2010;32:315-316.
29. Katayama H, Takeuchi M, Yoshino T et al. Epstein-Barr virus associated diffuse large B-cell lymphoma complicated by autoimmune hemolytic anemia and pure red cell aplasia. Leuk Lymphoma 2001;42:539-542. (Pubitemid 32725613)
30. Zhu K, Chen J, Chen S. Treatment of Epstein-Barr virus-associated lymphoproliferative disorder (EBV-PTLD) and pure red cell aplasia (PRCA) with Rituximab following unrelated cord blood transplantation: A case report and literature review. Hematology 2005;10:365-370. (Pubitemid 41806523)
31. Socinski MA, Ershler WB, Tosato G et al. Pure red blood cell aplasia associated with chronic Epstein-Barr virus infection: Evidence for T cell-mediated suppression of erythroid colony forming units. J Lab Clin Med 1984;104:995-1006. (Pubitemid 15091143)
32. Cohen H, Williams I, Matthey F et al. Reversible zidovudine-induced pure red-cell aplasia. AIDS 1989;3:177-178. (Pubitemid 19111445)
33. John MA, Rhemtula YA, Menezes CN et al. Lamivudine-induced red cell aplasia. J Med Microbiol 2008;57:1032-1035.
34. Weinkove R, Rangarajan S, van der Walt J et al. Zidovudine-induced pure red cell aplasia presenting after 4 years of therapy. AIDS 2005;19:2046-2047. (Pubitemid 41669035)
35. Costantini A, Giuliodoro S, Butini L et al. Abnormalities of erythropoiesis during HIV-1 disease: A longitudinal analysis. J Acquir Immune Defic Syndr 2009;52:70-74.
36. Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 2006;108:2509-2519.
37. Young NS, Scheinberg P, Calado RT. Aplastic anemia. Curr Opin Hematol 2008;15:162-168. (Pubitemid 351507566)
38. Yetgin S, Kuskonmaz B, Aytac S et al. The evaluation of acquired aplastic anemia in children and unexpected frequency of varicella-zoster virus association: A single-center study. Turk J Pediatr 2008;50:342-348.
39. Angelini P, Kavadas F, Sharma N et al. Aplastic anemia following varicella vaccine. Pediatr Infect Dis J 2009;28:746-748.
40. Scheinberg P, Fischer SH, Li L et al. Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia. Blood 2007;109:3219-3224. (Pubitemid 46578057)
41. Wondergem MJ, Stevens SJ, Janssen JJ et al. Monitoring of EBV reactivation is justified in patients with aplastic anemia treated with rabbit ATG as a second course of immunosuppression. Blood 2008;111:1739, author reply 1739-1740.
42. Albuquerque PL, Silva Junior GB, Diogenes SS et al. Dengue and aplastic anemia-A rare association. Travel Med Infect Dis 2009;7:118-120.
43. Rice J, Resar LM. Hematologic abnormalities associated with influenza A infection: A report of 3 cases. Am J Med Sci 1998;316:401-403. (Pubitemid 29019596)
44. Cariani E, Pelizzari AM, Rodella A et al. Immune-mediated hepatitis-associated aplastic anemia caused by the emergence of a mutant hepatitis B virus undetectable by standard assays. J Hepatol 2007;46:743-747. (Pubitemid 46420384)
45. Al Nahdi N, Wiesinger H, Sutherland H et al. Recurrent idiopathic acute hepatitis-associated aplastic anemia/pancytopenia fourteen years after initial episode. Ann Hepatol 2010;9:468-470.
46. Locasciulli A, Bacigalupo A, Bruno B et al. Hepatitis-associated aplastic anaemia: Epidemiology and treatment results obtained in Europe. A Report of The Ebmt Aplastic Anaemia Working Party. Br J Haematol 2010;149:890-895.
47. Ishimura M, Ohga S, Ichiyama M et al. Hepatitis-associated aplastic anemia during a primary infection of genotype 1a torque teno virus. Eur J Pediatr 2010;169:899-902.
48. El-Azami-El-Idrissi M, Franquin S, Day MJ et al. Distinct host-dependent pathogenic mechanisms leading to a similar clinical anemia after infection with lymphocytic choriomeningitis virus. Exp Biol Med 2005;230:865-871. (Pubitemid 41785887)
49. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: Cellular receptor for B19 parvovirus. Science 1993;262:114-117. (Pubitemid 23338882)
50. Brown KE, Hibbs JR, Gallinella G et al. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 1994;330:1192-1196. (Pubitemid 24121988)
51. Dessypris EN. Aplastic anemia and pure red cell aplasia. Curr Opin Hematol 1994;1:157-161.
52. Serjeant GR, Serjeant BE, Thomas PW et al. Human parvovirus infection in homozygous sickle cell disease. Lancet 1993;341:1237-1240. (Pubitemid 23146929)
53. Weigel-Kelley KA, Yoder MC, Srivastava A. Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: Requirement of functional activation of beta1 integrin for viral entry. Blood 2003;102:3927-3933. (Pubitemid 37486972)
54. Munakata Y, Saito-Ito T, Kumura-Ishii K et al. Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood 2005;106:3449-3456. (Pubitemid 41609180)